What You Should Know: - Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. - Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
4 Predictions for Diabetes Management and Technology in 2021
The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of technology to address dire patient needs. Health systems, physicians, and frontline staff pulled together in remarkable fashion to implement these emerging technologies that enhance the ways patients
Read More
Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
What You Should Know: - The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance. - The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million. - Digital diabetes solutions have disrupted the
Read More
Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring
What You Should Know: - Ascensia Diabetes Care and VisiQuate announced a
partnership to expand beyond blood glucose monitoring and provide holistic
diabetes management solutions. - The overall solution will provide integration with
Ascensia’s existing devices and digital diabetes solutions to enable it to
capture data from patients who have consented to provide their information. Ascensia Diabetes Care,
a Santa Rosa, CA-based provider of blood glucose monitoring systems
Read More
State of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan
What You Should Know: - Connecticut state Comptroller Kevin Lembo announces the launch of Livongo for Diabetes Management Program through the state health plan to deliver estimated annual savings to the state of approximately $3 million. - The program, launched in partnership with CVS Caremark and Livongo, is projected to significantly improve health care outcomes for thousands of people with diabetes covered by the state plan by providing them with comprehensive around-the-clock live
Read More
COVID-19: Glooko Offers Free Remote Care to Medical Clinics and People with Diabetes
What You Should Know: - Glooko today announced that during the COVID-19 pandemic they are taking action to serve the global diabetes community by providing a no-charge remote care solution that provides live patient-to-clinician connectivity. - To minimize the risk to people with diabetes during this time by broadening access to a remote medical appointment with healthcare providers, Glooko is offering its secure, privacy-protected remote care solution at no charge to medical clinics and
Read More
BCBS Kansas City to Offer Livongo for Diabetes Program to All Fully Insured Clients
- Livongo announced an expanded partnership with Blue Cross and Blue Shield of Kansas City to provide Livongo for Diabetes program to all Blue KC fully insured clients. - Blue KC was an early Livongo adopter and this expansion provides momentum as we continue to expand from working primarily with self-insured employers to broader markets including fully insured populations of our health plan clients.Livongo Health, Inc. (Nasdaq: LVGO), an Applied Health Signals company empowering people with
Read More
Drugmaker Bayer to License One Drop’s Digital Diabetes Management Platform, Leads $40M Series B Funding
- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More
Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores
One Drop, a digital blood glucose monitoring kit for diabetes management will now be available in select retail Apple stores, CNBC reports. Currently sold online in the Apple Store for $69.95, the digital diabetes kit includes a Bluetooth glucose meter, test strips, lancets (optional), and one year of free coaching from a certified diabetes coach.One Drop Blood Glucose MonitorOne Drop’s blood glucose meter ensures clinically proven accurate, reliable results in just five seconds. The meter then
Read More
Companion Medical Integrates Smart Insulin Pen with Rimidi Diabetes Management App
Rimidi and Companion Medical announced a first-of-its-kind partnership to enhance data visualization for clinicians treating high-risk patients with diabetes who are on insulin therapy. The collaboration integrates Companion Medical’s connected device, InPen™, the first and only FDA-cleared, smart insulin pen paired with an integrated diabetes management app, into Rimidi’s platform by pushing insulin dosing data from the InPen through the cloud.Integration BenefitsThis partnership reduces the
Read More
